The necessity for the coating of perfluorodecalin-filled poly(lactide-co-glycolide) microcapsules in the presence of physiological cholate concentrations: Tetronic-908 as an exemplary polymeric surfactant

Journal of Microencapsulation

Volumn 29, Issue 1, 2012, Pages 30-38

  Kirsch, M ^a   Bramey, T ^a   Waack, I N ^a   Petrat, F ^a   Mayer, C ^b   De Groot, H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adsorption; Encapsulation; Microencapsulation; PLGA

Indexed keywords

ALBUMIN; CHOLIC ACID; COPOLYMER; FIBRONECTIN; NANOCAPSULE; OXYGEN; PERFLUORODECALIN; POLYGLACTIN; SURFACTANT; TETRONIC 908; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; CELL CULTURE; CELL GROWTH; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; FIBROBLAST; INHIBITION KINETICS; LASER MICROSCOPY; MACROPHAGE; MATERIAL COATING; MICROCAPSULE; MICROENCAPSULATION; OXYGEN TRANSPORT; SUSPENSION;

ADSORPTION; ANIMALS; CAPSULES; CELL LINE; CHOLIC ACID; FLUOROCARBONS; MICE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYMERS; PROPYLENE GLYCOLS; SURFACE-ACTIVE AGENTS;

EID: 84855905978     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.629743     Document Type: Article

References (37)

1. Abramson N, Schur PH. The IgG subclasses of red cell antibodies and relationship to monocytes binding. Blood, 1972;40:500-8.
2. Bauer J, Zähres M, Zellermann A, Kirsch M, Petrat F, de Groot H, Mayer C. Perfluorocarbon-filled poly(lactide-co-gylcolide) nanocapsules as artificial oxygen carriers for blood substitutes: A physico-chemical assessment. J Microencapsul, 2010;27(2):122-32.
3. Beck LR, Pope VZ, Flowers CE, Cowsar DR, Tice TR, Lewis DH, Dunn RL, Moore AB, Gilley RM. Poly(DL-lactide-co-glycolids)/norethissterone microcapsules: An injectable biodegradable contraceptive. Biol Reprod, 1983;28:186-95. (Pubitemid 13130541)
4. Bergmeyer HU, Grassl M, Walter H-E., 1983. Biochemical reagents for general use. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim: Verlag Chemie. p. 165.
5. Bottalico LA, Betensky HT, Min YB, Weinstock SB. Perfluorochemical emulsions decrease Kupffer cell phagocytosis. Hepatology, 1991;14:169-74.
6. Brush T, Wing E, Straub A, Mathiowitz, E, Bernstein H. 1997. Mikroverkapselte fluorierte Gase zur Anwendung als bilderzeugende Mittel. Patent Application 69729088, 27 February.
7. Garvin K, Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res, 2005;437:105-10. (Pubitemid 41099074)
8. Harris JM, Zalipsky S., 1997. Poly(ethylene glycol), chemistry and biological applications. Washington, DC: American Chemical Society.
9. Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science, 2006;312(14):233-6.
10. Ikada Y, Tabata Y. Phagocytosis of bioactive microspheres. J Bioactive Compat Polym, 1986;1(1):32-46.
11. Illum L, Davis SS, Muller RH, Mak E, West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer-poloxamine 908. Life Sci, 1987;40:367-74.
12. Kanke M, Simmons GH, Weiss DL, Bivins BA, de Luca PP. Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. J Pharm Sci, 1980;69(7):755-62. (Pubitemid 11237850)
13. Kolb-Bachofen V, Abel F. Participation of D-galactose-specific receptors of liver macrophages in recognition of fibronectin-opsonized particles. Carbohydr Res, 1991;213:201-13.
14. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm, 2008;363(1-2):26-39.
15. Moghimi SM. Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block-copolymers. Adv Drug Delivery Rev, 1995;16:183-93.
16. Moghimi SM, Muir IS, Illum L, Davis SS, Kolb-Bachofen V. Coating particles with a block copolymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta, 1993;1179:157-65. (Pubitemid 23328718)
17. Moghimi SM, Porter CJH, Muir IS, Illum L, Davis SS. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophilic coating. Biochem Biophys Res Commun, 1991;177(2):861-6.
18. Newman MJ, Balusubramnian M, Todd CW. Development of adjuvant-active non-ionic block copolymers. Adv Drug Delivery Rev, 1998;32:199-223. (Pubitemid 28267410)
19. Patel HM. Serum opsonins and liposomes: Their interaction and opsono-phagocytosis. Crit Rev Ther Drug Carrier Syst, 1992;9(1):39-90.
20. Peters SC, Reis A, Noll T., 2005. Preparation of endothelial cells from micro-and macrovascular origin. In: Dhein S, Mohr SW, Delmar M, editors. Practical methods in cardiovascular research. Berlin: SpringerVerlag. pp. 610-29.
21. Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 2006;22:4397-402.
22. Ratzinger G, Fillafer C, Kerleta V, Wirth M, Gabor F. The role of surface functionalization in the design of PLGA micro- and nanoparticles. Crit Rev Ther Drug Carrier Syst, 2010;27(1):1-83.
23. Rauen U, Noll T, Piper M, Lauchart W, Becker HD, de Groot H. Endothelial cell toxicity of preservation solutions: Comparison of endothelial cells of different origin and dependence on growth state. Cryobiology, 1994;31:144-53. (Pubitemid 124011313)
24. Reed WP. Serum factor capable of opsonizing shigella for phagocytosis by polymorphonuclear neutrophils. Immunology, 1975;28:1051-9.
25. Rhodes J. Receptor for monomeric IgM on guinea pig splenic macrophages. Nature, 1973;243:527-8.
26. Riess JG. Oxygen carriers ("blood substitutes")-raison d'etre, chemistry, and some physiology. Chem Rev, 2001;101:2797-919. (Pubitemid 35377808)
27. Riess JG, Krafft MP., 2006. Fluorocarbon emulsions as in vivo oxygen delivery systems: Background and chemistry. In: Winslow RM, editor. Blood substitutes. Amsterdam: Academic Press/Elsevier. pp. 259-75.
28. Rudolph G, Endele R, Senn M, Stiehl A. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology, 1993;17:1028-32. (Pubitemid 23187407)
29. Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'Hagan DT. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther, 2004;4(4):483-91. (Pubitemid 38480548)
30. Singh M, Kazzaz J, Ugozzoli M, Malyala P, Chesko J, O'Hagan DT. Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems. Curr Drug Deliv, 2006;3(1):115-20.
31. Slack JD, Kanke M, Simmons GH, DeLuca PP. Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration. J Pharm Sci, 1981;70(6):660-4. (Pubitemid 11035298)
32. Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AGA, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS, et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)- poly(ethylene glycol) copolymers. Pharm Res, 1994;11(12):1800-8. (Pubitemid 24377094)
33. Tabata Y, Ikada Y. Macrophage phagocytosis of biodegradable micro-spheres composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res, 1988;22:837-58.
34. Tadros TF. 2005. Applied surfactants. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA.
35. Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem, 1991;266(35):23611-7. (Pubitemid 21908841)
36. van Furth R. Answered and unanswered questions about macrophages. Acta Paediatr Hung, 1989;29:11-21.
37. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm, 2008;364(2):298-327.